Crocin Combined with Cisplatin Regulates Proliferation, Apoptosis, and EMT of Gastric Cancer Cells via the FGFR3/MAPK/ERK Pathway In vitro and In vivo

被引:0
作者
Li, Yan [1 ]
Guo, Qi-Jing [1 ,2 ]
Chen, Rong [1 ]
Zhao, Linglin [2 ]
Cui, Xianshu [1 ]
Deng, Yingfang [1 ]
Luo, Yu-Shuang [1 ,2 ]
机构
[1] Qinghai Univ, Affiliated Hosp, Dept Oncol, Xining, Qinghai, Peoples R China
[2] Qinghai Univ, High Altitude Med Res Ctr, Minist Educ, Key Lab High Altitude Med,Qinghai Utah Joint Res K, Xining 810001, Qinghai, Peoples R China
关键词
Crocin; cisplatin; fibroblast growth factor receptor 3; gastric cancer; MAPK/ERK; signaling pathway; GROWTH; CARCINOMA;
D O I
10.2174/1568009624666230915111239
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Cisplatin (DDP)-based chemotherapy remains the main therapeutic strategy for human gastric cancer (GC). Combination therapy with Chinese medicine monomers and DDP has been investigated as a means to enhance the anti-tumor effect of DDP while reducing toxicity. Material and Methods: Previous studies have shown that crocin combined with DDP can inhibit the apoptosis of BG-823 GC cells. However, the mechanism of this combination therapy in inhibiting GC is not fully unclear. In this study, we measured the IC50 values of crocin combined with DDP in AGS cells and assessed its effect on cell proliferation using an MTT assay. Furthermore, we assessed apoptosis, cell migration, and EMT-related protein levels by using flow cytometry, scratch assay, and Western blotting, respectively. Our results showed that crocin combined with DDP inhibited the proliferation, induced apoptosis, and inhibited invasion and EMT. Next, we performed RNA sequence and KEGG enrichment analysis on GC cells treated with Crocin+DDP. Results: The results showed that the most significant factor down-regulated by this combination therapy was Fibroblast growth factor receptor 3 (FGFR3) expression and that a differential gene was enriched in the MAPK/ERK pathway. We further constructed an FGFR3 OE transfection plasmid to overexpress FGFR3 and evaluate its effects on proliferation, apoptosis, migration, EMT, and MAPK/ERK pathway proteins in GC cells. We also conducted subcutaneous tumorigenesis experiments in nude mice to evaluate the effects of crocin and DDP on the progression of GC xenografts in vivo. Finally, we performed a rescue experiment using the MAPK/ERK pathway inhibitor PD184352. Conclusion: Our results showed that up-regulation of FGFR3 reversed the inhibitory effect of crocin+DDP on the MAPK/ERK signaling pathway. Still, this effect could be counteracted by PD184352, which simultaneously regulated the proliferation, apoptosis, and EMT of AGS cells. In conclusion, crocin, combined with DDP, inhibits proliferation, apoptosis, and EMT of GC through the FRFR3/MAPK/ERK pathway.
引用
收藏
页码:835 / 845
页数:11
相关论文
共 31 条
  • [11] Tyrosine kinases as targets for cancer therapy
    Krause, DS
    Van Etten, RA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) : 172 - 187
  • [12] Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells
    Liu, Li
    Fan, Jingyan
    Ai, Guihai
    Liu, Jie
    Luo, Ning
    Li, Caixia
    Cheng, Zhongping
    [J]. BIOLOGICAL RESEARCH, 2019, 52 (1)
  • [13] MicroRNA-99a Suppresses Breast Cancer Progression by Targeting FGFR3
    Long, Xinghua
    Shi, Yu
    Ye, Peng
    Guo, Juan
    Zhou, Qian
    Tang, Yueting
    [J]. FRONTIERS IN ONCOLOGY, 2020, 9
  • [14] Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer
    Lou, Jian-Shu
    Zhao, Li-Ping
    Huang, Zhi-Hui
    Chen, Xia-Yin
    Xu, Jing-Ting
    Tai, William Chi-Shing
    Tsim, Karl W. K.
    Chen, Yi-Tao
    Xie, Tian
    [J]. PHYTOMEDICINE, 2021, 80
  • [15] Inhibitory Effect of Crocin Against Gastric Carcinoma via Regulating TPM4 Gene
    Luo, Yushuang
    Yu, Pengjie
    Zhao, Junhui
    Guo, Qijing
    Fan, Baohua
    Diao, Yinzhuo
    Jin, Yulong
    Wu, Jing
    Zhang, Chengwu
    [J]. ONCOTARGETS AND THERAPY, 2021, 14 : 111 - 122
  • [16] Luo YS, 2017, PAK J PHARM SCI, V30, P1629
  • [17] Cisplatin nephrotoxicity: a review of the literature
    Manohar, Sandhya
    Leung, Nelson
    [J]. JOURNAL OF NEPHROLOGY, 2018, 31 (01) : 15 - 25
  • [18] Nelson Katelyn N, 2018, Oncotarget, V9, P34306, DOI 10.18632/oncotarget.26142
  • [19] EMT Transition States during Tumor Progression and Metastasis
    Pastushenko, Ievgenia
    Blanpain, Cedric
    [J]. TRENDS IN CELL BIOLOGY, 2019, 29 (03) : 212 - 226
  • [20] An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients
    Piro, Geny
    Carbone, Carmine
    Cataldo, Ivana
    Di Nicolantonio, Federica
    Giacopuzzi, Simone
    Aprile, Giuseppe
    Simionato, Francesca
    Boschi, Federico
    Zanotto, Marco
    Mina, Maria Mihaela
    Santoro, Raffaela
    Merz, Valeria
    Sbarbati, Andrea
    de Manzoni, Giovanni
    Scarpa, Aldo
    Tortora, Giampaolo
    Melisi, Davide
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (24) : 6164 - 6175